119 research outputs found
Di-ureasil hybrids doped with LiBF4: attractive candidates as electrolytes for "Smart Windows"
The sol-gel process has been used to prepare hybrid electrolytes composed of a poly(oxyethylene) (POE)/siloxane hybrid network doped with lithium tetrafluoroborate (LiBF4) with compositions of n between ∞ and 2.5. In this context the lithium salt concentration is expressed in terms of the number of oxyethylene units in the organic component of the network per Li+ ion. Electrolyte samples with n ≥ 20 are thermally stable up to approximately 250 ºC. All the materials synthesized are semi-crystalline: in the composition range n ≥ 15 free crystalline POE exists and at 60 ≥ n ≥ 2.5 evidence of the presence of a crystalline POE/LiBF4 compound has been found. At n = 2.5 this latter crystalline phase coexists with free salt. The room temperature conductivity maximum of this electrolyte system is located at n = 10 (1.5x10-5 S cm-1 at 22 ºC). The electrochemical stability domain of the sample with n = 15 spans about 5.5 V versus Li/Li+. This new series of materials represents a promising alternative to the LiTFSI- and LiClO4-doped POE and POE/siloxane analogues. Preliminary tests performed with a prototype electrochromic device (ECD) comprising the sample with n = 8 as electrolyte and WO3 as cathodically coloring layer are extremely encouraging. The device exhibits switching time around 50 s, an optical density change of 0.13, open circuit memory of about 4 months and high coloration efficiency (106 cm2C-1 in the 3rd cycle).Fundação para a Ciência e a Tecnologi
European sea bass brain DLB-1 cell line is susceptible to nodavirus: A transcriptomic study
Viral diseases are responsible for high rates of mortality and subsequent economic losses in modern aquaculture. The nervous necrosis virus (NNV) produces viral encephalopathy and retinopathy (VER), which affects the fish central nervous system. It is considered one of the most serious viral diseases in marine aquaculture, the European sea bass (Dicentrarchus labrax) being amongst the most susceptible. We have evaluated the European sea bass brain derived cell line (DLB-1) susceptibility to NNV genotypes and evaluated its transcriptomic profile. DLB-1 cells supported NNV gene transcription and replication since strains belonging to the four NNV genotypes produce cytopathic effects. Afterwards, DLB-1 cells were infected with an RGNNV strain, the one which showed the highest replication, for 12 and 72 h and an RNA-seq analysis was performed to identify potential genes involved in the host-NNV interactions. Differential expression analysis showed the up-regulation of many genes related to immunity, heat-shock proteins or apoptosis but not to proteasome or autophagy processes. These data suggest that the immune response, mainly the interferon (IFN) pathway, is not powerful enough to abrogate the infection, and cells finally suffer stress and die by apoptosis liberating infective particles. GO enrichment also revealed, for the first time, the down-regulation of terms related to brain/neuron biology indicating molecular mechanisms causing the pathogenic effect of NNV. This study opens the way to understand key elements in sea bass brain and NNV interactions.Versión del edito
Análisis de la relevancia y factibilidad de indicadores de calidad en las unidades de nutrición
Introducción: La evaluación de la calidad en las actividades
sanitarias exige la elección de unos indicadores
acordes con los resultados que queremos medir. De todos
los posibles, debemos priorizar aquellos que nos permitan
obtener la información más relevante sin sobrecargar el
trabajo habitual de nuestras Unidades.
Objetivo: Conocer la opinión de los socios de SENPE
respecto a la relevancia y la viabilidad del uso de una
selección de indicadores de calidad para su aplicación en
nutrición clínica.
Métodos: Encuesta remitida mediante correo electrónico
a los socios de SENPE solicitando a los mismos su
opinión sobre 12 indicadores de calidad, valorándose
cada uno en cuanto a su relevancia y factibilidad de la
aplicación en su medio.
Resultados: Contestaron 40 encuestados de 40 centros
diferentes de 12 comunidades autónomas. En general, los
indicadores fueron considerados más relevantes que factibles.
Los indicadores mejor puntuados fueron: “identificación
en las bolsas de nutrición artificial”, “posición
semi-incorporada del paciente con nutrición enteral por
sonda nasogástrica” y “protocolos clínicos básicos”. Considerando
los indicadores por grupos (de estructura, proceso
o resultado) los mejor valorados fueron: “identificación
del paciente en las bolsas de nutrición artificial”
(estructura), “posición semi-incorporada” y “protocolos
clínicos básicos” (proceso), y “cumplimiento del objetivo
calórico” (resultado).
Conclusión: Los resultados de la encuesta permiten
seleccionar indicadores prioritarios para su aplicación en
las Unidades de NutriciónIntroduction: The quality assessment in health activities
requires the choice of indicators in line with the
results we want to measure. Of all possible, we should prioritize
those that allow us to obtain the most relevant
information without overloading the regular work of our
units.
Objective: To determine the opinion of the members of
SENPE regarding the relevance and feasibility of using a
selection of quality indicators designed for use in clinical
nutrition.
Methods: E-mail survey sent to members of SENPE
asking them their views on 12 quality indicators, evaluating
each in terms of their relevance and feasibility of
implementation in their environment.
Results: 40 respondents answered from 40 centers in 12
different regions. In general, the indicators were considered
more relevant than feasible. The indicators best
rated were: “identification in artificial nutrition bags,
“semi-recumbent position in patient with nasogastric
tube feeding” and “basic clinical protocols”. Considering
the type of indicator: “patient identification in the bags of
artificial nutrition (structure),” a semi-incorporated
“and” basic clinical protocols (process), and “fulfillment
of the caloric goal” (result).
Conclusion: The results of the survey can make a selection
of indicators that could be considered for first-line
introduction in a Nutrition Uni
Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid
Background
Obeticholic acid (OCA) was recently approved as the only on-label alternative for patients with primary biliary cholangitis (PBC) with intolerance or suboptimal response to ursodeoxycholic acid (UDCA). However, few data are available outside clinical trials.
Aim
To assess the effectiveness and safety of OCA in a real-world cohort of patients with non-effective UDCA therapy.
Methods
Open-label, prospective, real-world, multicentre study, enrolling consecutive patients who did not meet Paris II criteria, from 18 institutions in Spain and Portugal. Effectiveness was assessed by the changes in GLOBE and UK-PBC scores from baseline. POISE and Paris II criteria were evaluated after 12 months of OCA . Liver fibrosis was evaluated by FIB-4 and AST to platelet ratio index (APRI).
Results
One hundred and twenty patients were eligible, median time since PBC diagnosis 9.3 (4.0-13.8) years, 21.7% had cirrhosis, and 26.7% received had previous or concomitant treatment with fibrates. Seventy-eight patients completed at least 1 year of OCA. The Globe-PBC score decreased to 0.17 (95% CI 0.05 to 0.28; P = 0.005) and the UK-PBC score decreased to 0.81 (95% CI -0.19 to 1.80; P = 0.11). There was a significant decrease in alkaline phosphatase of 81.3 U/L (95% CI 42.5 to 120; P < 0.001), ALT 22.1 U/L (95% CI 10.4 to 33.8; P < 0.001) and bilirubin 0.12 mg/dL (95% CI 0 to 0.24; P = 0.044). FIB-4 and APRI remained stable. According to the POISE criteria, 29.5% (23 out of 78) achieved response. The adverse events rate was 35%; 11.67% discontinued (8.3% due to pruritus).
Conclusions
This study supports data from phase III trials with significant improvement of PBC-Globe continuous prognostic marker score among OCA-treated patients with good tolerability
Effectiveness and safety of sofosbuvir‐based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis: results of a multicenter real‐life cohort
[Abstract] Patients with HCV genotype 3 (GT3) infection and cirrhosis are currently the most difficult to cure. We report our experience with sofosbuvir+daclatasvir (SOF+DCV) or sofosbuvir/ledipasvir (SOF/LDV), with or without ribavirin (RBV) in clinical practice in this population. This was a multicenter observational study including cirrhotic patients infected by HCV GT3, treated with sofosbuvir plus an NS5A inhibitor (May 2014‐October 2015). In total, 208 patients were included: 98 (47%) treatment‐experienced, 42 (20%) decompensated and 55 (27%) MELD score >10. In 131 (63%), treatment was SOF+DCV and in 77 (37%), SOF/LDV. Overall, 86% received RBV. RBV addition and extension to 24 weeks was higher in the SOF/LDV group (95% vs 80%, P=.002 and 83% vs 72%, P=.044, respectively). A higher percentage of decompensated patients were treated with DCV than LDV (25% vs 12%, P=.013). Overall, SVR12 was 93.8% (195/208): 94% with SOF+DCV and 93.5% with SOF/LDV. SVR12 was achieved in 90.5% of decompensated patients. Eleven treatment failures: 10 relapses and one breakthrough. RBV addition did not improve SVR (RR: 1.08; P=.919). The single factor associated with failure to achieve SVR was platelet count <75×10E9/mL (RR: 3.50, P=.019). In patients with MELD <10, type of NS5A inhibitor did not impact on SVR12 (94% vs 97%; adjusted RR: 0.49). Thirteen patients (6.3%) had serious adverse events, including three deaths (1.4%) and one therapy discontinuation (0.5%), higher in decompensated patients (16.7% vs 3.6%, P<.006). In patients with GT3 infection and cirrhosis, SVR12 rates were high with both SOF+DCV and SOF/LDV, with few serious adverse events
Nodavirus colonizes and replicates in the testis of gilthead seabream and European sea bass modulating its immune and reproductive functions
Viruses are threatening pathogens for fish aquaculture. Some of them are transmitted
through gonad fluids or gametes as occurs with nervous necrosis virus (NNV). In order to
be transmitted through the gonad, the virus should colonize and replicate inside some cell
types of this tissue and avoid the subsequent immune response locally. However, whether
NNV colonizes the gonad, the cell types that are infected, and how the immune response in
the gonad is regulated has never been studied. We have demonstrated for the first time the
presence and localization of NNV into the testis after an experimental infection in the European
sea bass (Dicentrarchus labrax), and in the gilthead seabream (Sparus aurata), a very
susceptible and an asymptomatic host fish species, respectively. Thus, we localized in the
testis viral RNA in both species using in situ PCR and viral proteins in gilthead seabream by
immunohistochemistry, suggesting that males might also transmit the virus. In addition, we
were able to isolate infective particles from the testis of both species demonstrating that
NNV colonizes and replicates into the testis of both species. Blood contamination of the tissues
sampled was discarded by completely fish bleeding, furthermore the in situ PCR and
immunocytochemistry techniques never showed staining in blood vessels or cells. Moreover,
we also determined how the immune and reproductive functions are affected comparing
the effects in the testis with those found in the brain, the main target tissue of the virus.
Interestingly, NNV triggered the immune response in the European sea bass but not in the
gilthead seabream testis. Regarding reproductive functions, NNV infection alters 17β-estradiol
and 11-ketotestosterone production and the potential sensitivity of brain and testis to
these hormones, whereas there is no disruption of testicular functions according to several
reproductive parameters. Moreover, we have also studied the NNV infection of the testis in
vitro to assess local responses. Our in vitro results show that the changes observed on the expression of immune and reproductive genes in the testis of both species are different to
those observed upon in vivo infections in most of the casesMINECO and FEDER (AGL2010-20801-C02-01; AGL2010-20801-C02-02; AGL2013-43588-P); Fundación Séneca (04538/GERM/06)Versión del editor4,411
- …